Tenaya Therapeutics Q4 EPS $(0.40) Beats $(0.44) Estimate
Portfolio Pulse from Happy Mohamed
Tenaya Therapeutics (NASDAQ:TNYA) reported Q4 earnings with losses of $(0.40) per share, surpassing the analyst consensus estimate of $(0.44) by 9.09%. This represents a 34.43% improvement over the previous year's losses of $(0.61) per share.
March 18, 2024 | 8:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tenaya Therapeutics reported a smaller-than-expected loss per share for Q4, indicating a significant improvement over the previous year.
Beating EPS estimates typically leads to positive investor sentiment, potentially driving up the stock price in the short term. The significant year-over-year improvement further strengthens the case for a positive impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100